{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:02Z","timestamp":1792788182245,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303181"],"award-info":[{"award-number":["82303181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403279"],"award-info":[{"award-number":["82403279"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical science and technology innovation platform support project of Zhongnan Hospital of Wuhan University","award":["PTXM2025027"],"award-info":[{"award-number":["PTXM2025027"]}],"id":[{"id":"https:\/\/ror.org\/01v5mqw79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Program of Excellent Doctoral (Postdoctoral) of Zhongnan Hospital of Wuhan University","award":["ZNYB2022003"],"award-info":[{"award-number":["ZNYB2022003"]}],"id":[{"id":"https:\/\/ror.org\/01v5mqw79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Science and Technology Innovation Cultivation Fund of Zhongnan Hospital of Wuhan University","award":["CXPY2023018"],"award-info":[{"award-number":["CXPY2023018"]}],"id":[{"id":"https:\/\/ror.org\/01v5mqw79","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08815-6","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:45:00Z","timestamp":1786970700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Guanylate-binding protein 2 (GBP2) drives pancreatic cancer cell proliferation by promoting cell cycle progression via the SP1\/SKP2\/P27 axis"],"prefix":"10.1186","volume":"24","author":[{"given":"Shilin","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntian","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengning","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-966X","authenticated-orcid":false,"given":"Haizhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"8815_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8815_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/MPA.0b013e318163a329","volume":"37","author":"TL Fitzgerald","year":"2008","unstructured":"Fitzgerald TL, Hickner ZJ, Schmitz M, Kort EJ. Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry. Pancreas. 2008;37:134\u20138.","journal-title":"Pancreas"},{"key":"8815_CR3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: Advances and challenges. Cell. 2023;186:1729\u201354.","journal-title":"Cell"},{"key":"8815_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pan.2017.11.007","volume":"18","author":"A Kanno","year":"2018","unstructured":"Kanno A, Masamune A, Hanada K, Maguchi H, Shimizu Y, Ueki T, et al. Multicenter study of early pancreatic cancer in Japan. Pancreatology. 2018;18:61\u20137.","journal-title":"Pancreatology"},{"key":"8815_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1084\/jem.20182031","volume":"216","author":"K Tretina","year":"2019","unstructured":"Tretina K, Park ES, Maminska A, MacMicking JD. Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease. J Exp Med. 2019;216:482\u2013500.","journal-title":"J Exp Med"},{"key":"8815_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.tibs.2023.07.002","volume":"48","author":"M Kirkby","year":"2023","unstructured":"Kirkby M, Enosi Tuipulotu D, Feng S, Lo Pilato J, Man SM. Guanylate-binding proteins: mechanisms of pattern recognition and antimicrobial functions. Trends Biochem Sci. 2023;48:883\u201393.","journal-title":"Trends Biochem Sci"},{"key":"8815_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12282-012-0404-8","volume":"21","author":"P Godoy","year":"2014","unstructured":"Godoy P, Cadenas C, Hellwig B, Marchan R, Stewart J, Reif R, et al. Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response. Breast Cancer. 2014;21:491\u20139.","journal-title":"Breast Cancer"},{"key":"8815_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/CJI.0000000000000421","volume":"45","author":"S Zhang","year":"2022","unstructured":"Zhang S, Chen K, Zhao Z, Zhang X, Xu L, Liu T, et al. Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM). J Immunother. 2022;45:274\u201383.","journal-title":"J Immunother"},{"key":"8815_CR9","doi-asserted-by":"crossref","unstructured":"Wang H, Zhou Y, Zhang Y, Fang S, Zhang M, Li H, et al. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target. J Immunother Cancer. 2022;10.","DOI":"10.1136\/jitc-2021-004302"},{"key":"8815_CR10","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1038\/s41388-020-1348-7","volume":"39","author":"S Yu","year":"2020","unstructured":"Yu S, Yu X, Sun L, Zheng Y, Chen L, Xu H, et al. GBP2 enhances glioblastoma invasion through Stat3\/fibronectin pathway. Oncogene. 2020;39:5042\u201355.","journal-title":"Oncogene"},{"key":"8815_CR11","doi-asserted-by":"publisher","first-page":"e11423","DOI":"10.7717\/peerj.11423","volume":"9","author":"B Liu","year":"2021","unstructured":"Liu B, Huang R, Fu T, He P, Du C, Zhou W, et al. GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma. PeerJ. 2021;9:e11423.","journal-title":"PeerJ"},{"key":"8815_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","volume":"10","author":"I Pellarin","year":"2025","unstructured":"Pellarin I, Dall\u2019Acqua A, Favero A, Segatto I, Rossi V, Crestan N, et al. Cyclin-dependent protein kinases and cell cycle regulation in biology and disease. Signal Transduct Target Ther. 2025;10:11.","journal-title":"Signal Transduct Target Ther"},{"key":"8815_CR13","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1073\/pnas.081474898","volume":"98","author":"M Gstaiger","year":"2001","unstructured":"Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A. 2001;98:5043\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8815_CR14","doi-asserted-by":"publisher","first-page":"216733","DOI":"10.1016\/j.canlet.2024.216733","volume":"587","author":"J Yuan","year":"2024","unstructured":"Yuan J, Zhu Z, Zhang P, Ashrafizadeh M, Abd El-Aty AM, Hac\u0131m\u00fcft\u00fco\u011flu A, et al. SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation. Cancer Lett. 2024;587:216733.","journal-title":"Cancer Lett"},{"key":"8815_CR15","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/med.21675","volume":"40","author":"MD Asmamaw","year":"2020","unstructured":"Asmamaw MD, Liu Y, Zheng YC, Shi XJ, Liu HM. Skp2 in the ubiquitin-proteasome system: A comprehensive review. Med Res Rev. 2020;40:1920\u201349.","journal-title":"Med Res Rev"},{"key":"8815_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/jcp.1111","volume":"188","author":"AR Black","year":"2001","unstructured":"Black AR, Black JD, Azizkhan-Clifford J. Sp1 and kr\u00fcppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol. 2001;188:143\u201360.","journal-title":"J Cell Physiol"},{"key":"8815_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0092-8674(83)90210-6","volume":"35","author":"WS Dynan","year":"1983","unstructured":"Dynan WS, Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell. 1983;35:79\u201387.","journal-title":"Cell"},{"key":"8815_CR18","doi-asserted-by":"crossref","unstructured":"Zou Y, Wu S, Hu Q, Zhou H, Ge Y, Ju Z, et al. Sonic hedgehog restrains the ubiquitin-dependent degradation of SP1 to inhibit neuronal\/glial senescence associated phenotypes in chemotherapy-induced peripheral neuropathy via the TRIM25-CXCL13 axis. J Adv Res. 2024.","DOI":"10.1016\/j.jare.2024.03.006"},{"key":"8815_CR19","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41388-024-03003-6","volume":"43","author":"J Wang","year":"2024","unstructured":"Wang J, Zhao E, Geng B, Zhang W, Li Z, Liu Q, et al. Downregulation of UBB potentiates SP1\/VEGFA-dependent angiogenesis in clear cell renal cell carcinoma. Oncogene. 2024;43:1386\u201396.","journal-title":"Oncogene"},{"key":"8815_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-biochem-061516-044859","volume":"86","author":"A Varshavsky","year":"2017","unstructured":"Varshavsky A. The Ubiquitin System, Autophagy, and Regulated Protein Degradation. Annu Rev Biochem. 2017;86:123\u20138.","journal-title":"Annu Rev Biochem"},{"key":"8815_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13046-020-01617-8","volume":"39","author":"JJ Chen","year":"2020","unstructured":"Chen JJ, Ren YL, Shu CJ, Zhang Y, Chen MJ, Xu J, et al. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25\/SP1\/MMP2 axis. J Exp Clin Cancer Res. 2020;39:118.","journal-title":"J Exp Clin Cancer Res"},{"key":"8815_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jare.2024.03.006","volume":"68","author":"Y Zou","year":"2025","unstructured":"Zou Y, Wu S, Hu Q, Zhou H, Ge Y, Ju Z, et al. Sonic hedgehog restrains the ubiquitin-dependent degradation of SP1 to inhibit neuronal\/glial senescence associated phenotypes in chemotherapy-induced peripheral neuropathy via the TRIM25-CXCL13 axis. J Adv Res. 2025;68:387\u2013402.","journal-title":"J Adv Res"},{"key":"8815_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/SLA.0000000000003284","volume":"273","author":"MJ Truty","year":"2021","unstructured":"Truty MJ, Kendrick ML, Nagorney DM, Smoot RL, Cleary SP, Graham RP, et al. Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline\/Locally Advanced Pancreatic Cancer. Ann Surg. 2021;273:341\u20139.","journal-title":"Ann Surg"},{"key":"8815_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","volume":"17","author":"L Buscail","year":"2020","unstructured":"Buscail L, Bournet B, Cordelier P. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2020;17:153\u201368.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8815_CR25","doi-asserted-by":"publisher","first-page":"103897","DOI":"10.1016\/j.ebiom.2022.103897","volume":"77","author":"X Zhang","year":"2022","unstructured":"Zhang X, Mao T, Zhang B, Xu H, Cui J, Jiao F, et al. Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer. EBioMedicine. 2022;77:103897.","journal-title":"EBioMedicine"},{"key":"8815_CR26","doi-asserted-by":"publisher","first-page":"17504","DOI":"10.1002\/cam4.6347","volume":"12","author":"Y Ning","year":"2023","unstructured":"Ning Y, Fang S, Fang J, Lin K, Nie H, Xiong P, et al. Guanylate-binding proteins signature predicts favorable prognosis, immune-hot microenvironment, and immunotherapy response in hepatocellular carcinoma. Cancer Med. 2023;12:17504\u201321.","journal-title":"Cancer Med"},{"key":"8815_CR27","doi-asserted-by":"publisher","first-page":"2521451","DOI":"10.1080\/07853890.2025.2521451","volume":"57","author":"S Fang","year":"2025","unstructured":"Fang S, Ding Y, Jia Y, Gao L, Ning Y, Wu G, et al. Identification of GBP6 as a potential prognostic biomarker in esophageal carcinoma by integrated bioinformatics analysis and experiment validation. Ann Med. 2025;57:2521451.","journal-title":"Ann Med"},{"key":"8815_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00262-024-03786-3","volume":"73","author":"Y Tasiheng","year":"2024","unstructured":"Tasiheng Y, Lin X, Wang X, Zou X, Chen Y, Yan Y, et al. DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancer. Cancer Immunol Immunother. 2024;73:208.","journal-title":"Cancer Immunol Immunother"},{"key":"8815_CR29","doi-asserted-by":"crossref","unstructured":"Zhang W, Tang X, Peng Y, Xu Y, Liu L, Liu S. GBP2 enhances paclitaxel sensitivity in triple\u2013negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K\/AKT\/mTOR pathway. Int J Oncol. 2024;64.","DOI":"10.3892\/ijo.2024.5622"},{"key":"8815_CR30","doi-asserted-by":"publisher","first-page":"155438","DOI":"10.1016\/j.prp.2024.155438","volume":"260","author":"C Li","year":"2024","unstructured":"Li C, Jing J, Wang Y, Jiang H. CENPA facilitates glioma stem cell stemness and suppress ferroptosis to accelerate glioblastoma multiforme progression by promoting GBP2 transcription. Pathol Res Pract. 2024;260:155438.","journal-title":"Pathol Res Pract"},{"key":"8815_CR31","doi-asserted-by":"publisher","first-page":"100137","DOI":"10.1016\/j.bneo.2025.100137","volume":"2","author":"SM Zimmerman","year":"2025","unstructured":"Zimmerman SM, Procasky SJ, Smith SR, Liu JY, Torrice C, Souroullas GP. Developmental stage and cellular context determine oncogenic and molecular outcomes of Ezh2 (Y641F) mutation in hematopoiesis. Blood Neoplasia. 2025;2:100137.","journal-title":"Blood Neoplasia"},{"key":"8815_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2009.06.032","volume":"288","author":"WC Hung","year":"2010","unstructured":"Hung WC, Tseng WL, Shiea J, Chang HC. Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett. 2010;288:156\u201361.","journal-title":"Cancer Lett"},{"key":"8815_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41419-022-04685-0","volume":"13","author":"X Yu","year":"2022","unstructured":"Yu X, Zhou L, Liu W, Liu L, Gao F, Li W, et al. Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer. Cell Death Dis. 2022;13:249.","journal-title":"Cell Death Dis"},{"key":"8815_CR34","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1053\/j.gastro.2009.08.005","volume":"137","author":"DF Calvisi","year":"2009","unstructured":"Calvisi DF, Ladu S, Pinna F, Frau M, Tomasi ML, Sini M, et al. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Gastroenterology. 2009;137:1816\u2013e18261811.","journal-title":"Gastroenterology"},{"key":"8815_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/01.mpa.0000220862.78248.c4","volume":"32","author":"T Einama","year":"2006","unstructured":"Einama T, Kagata Y, Tsuda H, Morita D, Ogata S, Ueda S, et al. High-level Skp2 expression in pancreatic ductal adenocarcinoma: correlation with the extent of lymph node metastasis, higher histological grade, and poorer patient outcome. Pancreas. 2006;32:376\u201381.","journal-title":"Pancreas"},{"key":"8815_CR36","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/cvr\/cvab132","volume":"118","author":"K Jeong","year":"2022","unstructured":"Jeong K, Murphy JM, Ahn EE, Lim SS. FAK in the nucleus prevents VSMC proliferation by promoting p27 and p21 expression via Skp2 degradation. Cardiovasc Res. 2022;118:1150\u201363.","journal-title":"Cardiovasc Res"},{"key":"8815_CR37","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41556-024-01372-4","volume":"26","author":"D Murthy","year":"2024","unstructured":"Murthy D, Attri KS, Shukla SK, Thakur R, Chaika NV, He C, et al. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nat Cell Biol. 2024;26:613\u201327.","journal-title":"Nat Cell Biol"},{"key":"8815_CR38","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s42003-024-06477-y","volume":"7","author":"X Zeng","year":"2024","unstructured":"Zeng X, Lu Y, Zeng T, Liu W, Huang W, Yu T, et al. RNA demethylase FTO participates in malignant progression of gastric cancer by regulating SP1-AURKB-ATM pathway. Commun Biol. 2024;7:800.","journal-title":"Commun Biol"},{"key":"8815_CR39","doi-asserted-by":"crossref","unstructured":"Safe S. Specificity proteins (Sp) and Cancer. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms24065164"},{"key":"8815_CR40","doi-asserted-by":"publisher","first-page":"108672","DOI":"10.1016\/j.pharmthera.2024.108672","volume":"260","author":"J Portugal","year":"2024","unstructured":"Portugal J. Mithramycin and its analogs: Molecular features and antitumor action. Pharmacol Ther. 2024;260:108672.","journal-title":"Pharmacol Ther"},{"key":"8815_CR41","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1038\/s41388-022-02397-5","volume":"41","author":"H Xu","year":"2022","unstructured":"Xu H, Jin J, Chen Y, Wu G, Zhu H, Wang Q, et al. GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair. Oncogene. 2022;41:3876\u201385.","journal-title":"Oncogene"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08815-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08815-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08815-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:48:19Z","timestamp":1789555699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08815-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8815"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08815-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Thirteen resected human PDAC tissues were obtained from patients at Zhongnan Hospital of Wuhan University. The Study was approved by the Ethics Committee of Zhongnan Hospital of Wuhan University (approval No. ZN2025010K). All the paraffin-embedded PDAC specimens were obtained from the Biobank of the National Engineering Center for Biochip in Shanghai (the National Human Genetic Resources Sharing Service Platform, No. 2005DKA21300). Ethical approval (No. SHYJS-CP-1901009) for the use of TMAs was granted by the Clinical Research Ethics Committee in Outdo Biotech (Shanghai, China). All animal experiments were approved by the Experimental Animal Welfare Ethics Committee of Zhongnan Hospital (No. ZN2024047). All animal housing, handling, surgical interventions and euthanasia procedures were performed humanely in compliance with the ARRIVE 2.0 reporting guidelines, the core 3Rs ethical principles, and the Chinese national standard GB\/T 35892-2018 for laboratory animal welfare ethical review.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1189"}}